We are live on ! Find out more
PC

Pier Capital Portfolio holdings

AUM $755M
1-Year Est. Return 94.38%
This Fund
S&P 500
This Quarter Est. Return
+18.25%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$699M
AUM Growth
+$78.9M
Cap. Flow
-$3.1M
Cap. Flow %
-0.44%
Top 10 Hldgs %
17.4%
Holding
139
New
21
Increased
40
Reduced
54
Closed
22

Top Sells

Rank Stock Value
1
AMED
Amedisys
AMED
+$9.07M
2
FCN icon
FTI Consulting
FCN
+$8.27M
3
CXM icon
Sprinklr
CXM
+$7.73M
4
SHLS icon
Shoals Technologies Group
SHLS
+$6.76M
5
PZZA icon
Papa John's
PZZA
+$6.76M

Sector Composition

Rank Sector Weight
1 Technology 26.72%
2 Healthcare 21.49%
3 Industrials 18.54%
4 Consumer Discretionary 12.8%
5 Consumer Staples 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DUOL icon
126
Duolingo
DUOL
$6.74B
-28,564
Closed -$4.74M
FOXF icon
127
Fox Factory Holding Corp
FOXF
$886M
-42,075
Closed -$4.17M
HQY icon
128
HealthEquity
HQY
$8.83B
-53,832
Closed -$3.93M
JAMF
129
DELISTED
Jamf
JAMF
-439
Closed -$7.75K
MTZ icon
130
MasTec
MTZ
$22.6B
-86
Closed -$6.19K
PODD icon
131
Insulet
PODD
$10.1B
-1,810
Closed -$289K
PZZA icon
132
Papa John's
PZZA
$793M
-99,042
Closed -$6.76M
ROKU icon
133
Roku
ROKU
$22.9B
-41,860
Closed -$2.95M
SEDG icon
134
SolarEdge
SEDG
$1.98B
-2,022
Closed -$262K
SHLS icon
135
Shoals Technologies Group
SHLS
$1.4B
-370,250
Closed -$6.76M
TGTX icon
136
TG Therapeutics
TGTX
$7.58B
-392,709
Closed -$3.28M
ATSG
137
DELISTED
Air Transport Services Group
ATSG
-283
Closed -$5.91K
SILK
138
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
-182,209
Closed -$2.73M
PNT
139
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
-732,936
Closed -$4.89M

Similar funds

Pier Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Pier Capital held 139 positions worth $699M, up 13% from $620M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Pier Capital's Q4 2023 filing shows 21 new, 40 increased, 54 reduced and 22 closed positions. Its largest new stake was Goosehead Insurance: 128,793 shares worth $9.76M. The largest sale was Amedisys, an estimated $9.07M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Pier Capital's largest Q4 2023 buy was Goosehead Insurance: 128,793 shares worth $9.76M.
  • Pier Capital added most to Stevanato in Q4 2023, an estimated $3.93M increase.
  • Pier Capital's biggest Q4 2023 reduction was FTI Consulting, cutting an estimated $8.27M.
  • Pier Capital fully exited Amedisys in Q4 2023, selling an estimated $9.07M.
  • Pier Capital's ten largest holdings make up 17% of its $699M portfolio in Q4 2023.
  • Pier Capital opened 21 new positions and closed 22 in Q4 2023.
  • Pier Capital's portfolio value rose 13% quarter-over-quarter to $699M.

Based on Pier Capital's 13F filing for Q4 2023, filed 15 Feb 2024.